Skip to main content
Azenta, Inc. logo

Azenta, Inc. — Investor Relations & Filings

Ticker · AZTA ISIN · US1143401024 LEI · 35ZN6X1ANPH25YN32Y17 US Professional, scientific and technical activities
Open in API
Filings indexed 1,365 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country US United States of America
Listing US AZTA

About Azenta, Inc.

https://www.azenta.com/

Azenta, Inc. provides sample exploration and management solutions for the life sciences industry. The company's portfolio includes automated sample storage systems ranging from ambient to cryogenic temperatures, consumables and instruments, and sample management software (LIMS). It also offers a range of services, including sample storage and biobanking, clinical trial support, cold chain logistics, and sample relocation. Through its GENEWIZ brand, Azenta delivers multiomics and synthesis solutions, such as next-generation sequencing, Sanger sequencing, and gene synthesis. These integrated offerings are designed to help life sciences organizations accelerate the research, development, and delivery of new breakthroughs and therapies.

Recent filings

Filing Released Lang Actions
FORM SD
Regulatory Filings Classification · 90% confidence The document is a Form SD (“Specialized Disclosure Report”) filed with the SEC under Rule 13p-1 regarding conflict minerals, not an annual or quarterly financial report, board change notice, earnings release, or other specific category. It is a regulatory compliance filing, so it falls under the general “Regulatory Filings” category.
2026-05-26 English
S-8 - Azenta, Inc. (0000933974) (Filer)
Share Issue/Capital Change Classification · 90% confidence The document is a Form S-8 registration statement filed with the SEC to register an additional 2,750,000 shares of common stock under the company’s 2020 Equity Incentive Plan. It details the purpose of registering new shares for future issuance under an employee equity plan, which constitutes a capital change/share issuance announcement rather than a full annual report, proxy, or management discussion. Therefore, it fits the ‘Share Issue/Capital Change’ category.
2026-05-08 English
10-Q - Azenta, Inc. (0000933974) (Filer)
Interim / Quarterly Report H1 2026
2026-05-08 English
8-K - Azenta, Inc. (0000933974) (Filer)
Report Publication Announcement Classification · 90% confidence The document is a short Form 8-K filed under Item 2.02 “Results of Operations and Financial Condition” that simply announces a press release of quarterly results (Exhibit 99.1) and states that it is attached. No actual financial data or full earnings release text is included in the body of this filing. Under the “menu vs meal” rule, this is an announcement of the publication of a report (the earnings press release), not the report itself. Therefore, it should be classified as a Report Publication Announcement (RPA).
2026-05-05 English
8-K - Azenta, Inc. (0000933974) (Filer)
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated April 6, 2026, reporting changes in the company's senior management, specifically the departure of a President and the appointment of a new President for the Multiomics business segment. It details the terms of employment, severance, and consulting agreements related to these management changes. The document does not contain financial statements or financial performance data but focuses on management appointments and departures. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). Therefore, this document is best classified as MANG.
2026-04-07 English
4 Filing
Director's Dealing
2026-02-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.